COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 689: Articles 6881-6890  | Next

A specific anti-IFITM2 antibody bars the way to SARS-CoV-2 entry into host cells.
Basile, A., Zannella, C., De Marco, M., Franci, G., Galdiero, M., Sanna, G., Manzin, A., Chetta, M., Turco, M. C., Rosati, A., Marzullo, L.
10.1101/2022.08.04.502768 — Posted: 2022-08-04
Double-dose mRNA vaccination to SARS-CoV-2 progressively increases recognition of variants-of-concern by Spike RBD-specific memory B cells
Hartley, G. E., Edwards, E. S. J., Varese, N., Boo, I., Aui, P. M., Bornheimer, S. J., Hogarth, P. M., Drummer, H. E., O'Hehir, R. E., van Zelm, M. C.
10.1101/2022.08.03.502703 — Posted: 2022-08-04
"I don't know what to do or where to go". experiences of accessing healthcare support from the perspectives of people living with Long Covid and healthcare professionals: A qualitative study in Bradford, UK.
Baz, S. A., Fang, C., Carpentieri, J., Sheard, L.
10.1101/2022.08.04.22278204 — Posted: 2022-08-04
Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir
Dai, E. Y., Lee, K. A., Nathanson, A. B., Leonelli, A. T., Petros, B. A., Brock-Fisher, T., Dobbins, S. T., MacInnis, B. L., Capone, A., Littlehale, N., Boucau, J., Marino, C., Barczak, A. K., Sabeti, P. C., Springer, M., Stephenson, K. E.
10.1101/2022.08.04.22278378 — Posted: 2022-08-04
SARS-CoV-2 BA.4/5 Spike recognition and neutralization elicited after the third dose of mRNA vaccine
Tauzin, A., Chatterjee, D., Dionne, K., Gendron-Lepage, G., Medjahed, H., Bo, Y., Perreault, J., Goyette, G., Gokool, L., Arlotto, P., Morrisseau, C., Tremblay, C., Martel-Laferriere, V., Kaufmann, D. E., De Serres, G., Levade, I., Cote, M., Bazin, R., Finzi, A.
10.1101/2022.08.03.22278386 — Posted: 2022-08-04
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic.
Bonilla, H., Quach, T., Tiwari, A., Bonilla, A., Miglis, M. G., Yang, P., Eggert, L., Sharifi, H., Horomanski, A., Subramanian, A. K., Smirnoff, L., Simpson, N., Halawi, H., Sum-Ping, O., Kalinowski, A., Patel, Z., Shafer, R. W., Geng, L.
10.1101/2022.08.03.22278363 — Posted: 2022-08-04
Association of mortality and aspirin use for COVID-19 residents at VA Community Living Center Nursing Homes
Abul, Y., Devone, F., Bayer, T., Halladay, C., McConeghy, K., Mujahid, N., Singh, M., Leeder, C., Gravenstein, S., Rudolph, J. L.
10.1101/2022.08.03.22278392 — Posted: 2022-08-04
The association between experience of COVID-19-related discrimination and psychological distress among healthcare workers for six national medical research centers in Japan
Manandhar Shrestha, R., Inoue, Y., Yamamoto, S., Fukunaga, A., Sampei, M., Okubo, R., Morisaki, N., Ohmagari, N., Funaki, T., Ishitsuka, K., Yamaguchi, K., Sasaki, Y., Takeda, K., Miyama, T., Kojima, M., Nakagawa, T., Nishimura, K., Ogata, S., Umezawa, J., Tanaka, S., Inoue, M., Konishi, M., Miyo, K., Mizoue, T.
10.1101/2022.08.03.22278304 — Posted: 2022-08-04
A long interval between priming and boosting SARS-CoV-2 mRNA vaccine doses enhances B cell responses with limited impact on T cell immunity
Nicolas, A., Sannier, G., Dube, M., Nayrac, M., Painter, M. M., Goel, R. R., Laporte, M., Medjahed, H. R., Williams, J., Brassard, N., Niessl, J., Gokool, L., Morrisseau, C., Arlotto, P., Tremblay, C., Martel-Laferriere, V., Finzi, A., Greenplate, A., Wherry, E. J., Kaufmann, D. E.
10.1101/2022.08.03.502672 — Posted: 2022-08-04
Neutralization sensitivity of the SARS-CoV-2 Omicron BA.2.75 sublineage
Gruell, H., Vanshylla, K., Tober-Lau, P., Hillus, D., Sander, L. E., Kurth, F., Klein, F.
10.1101/2022.08.04.502609 — Posted: 2022-08-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).